PillGlycopyrrolate
Glycopyrrolate
21 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it21 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Medical Purchasing Solutions, LLC | unknown | 12 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 10 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | unknown | 8 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | unknown | 8 | SUPPLYING |
| Xiromed, LLC. | unknown | 7 | SUPPLYING |
| Lifestar Pharma LLC | unknown | 4 | SUPPLYING |
| Nivagen Pharmaceuticals, Inc. | unknown | 4 | SUPPLYING |
| Accord Healthcare Inc. | unknown | 4 | SUPPLYING |
| Alembic Pharmaceuticals Limited | unknown | 4 | SUPPLYING |
| Solco Healthcare US, LLC | unknown | 4 | SUPPLYING |
| Sandoz Inc | unknown | 4 | SUPPLYING |
| BE Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 4 | SUPPLYING |
| Caplin Steriles Limited | unknown | 4 | SUPPLYING |
| Gland Pharma Limited | unknown | 4 | SUPPLYING |
+ 7 more labelers
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 6, 2023RECALLRecall (Class III): GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662…
Labeling: Label Mix-up — Recalling firm: HF Acquisition Co LLC — Distributed in TX, AZ and CA only
- Feb 7, 2023RECALLRecall (Class II): Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) 20 mL Multiple Dose Vial, 10vial carton, Rx Only, Manufactured for…
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
- Feb 7, 2023RECALLRecall (Class II): Glycopyrrolate Injection, USP, 0.4 mg/2 mL (0.2 mg/mL) 2 mL Single Dose Vial X 25 vials carton, Rx Only, Manufactured f…
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
- Feb 7, 2023RECALLRecall (Class II): Glycopyrrolate Injection, USP, 0.2 mg/mL, 1 mL Single Dose Vial x 25 vials, Rx Only, Manufactured for: Accord Healthcar…
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
- Feb 7, 2023RECALLRecall (Class II): Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) 5 mL Multiple Dose Vial, x 10 vials carton, Rx Only, Manufactured f…
CGMP Deviations: recalling drug products following an FDA inspection. — Recalling firm: Accord Healthcare, Inc. — United States including Puerto Rico and Canada
- Jan 28, 2021RECALLRecall (Class III): Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials Rx Only, Manufactured for: Accord Hea…
Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials — Recalling firm: Accord Healthcare, Inc. — Nationwide